Michael A. Darwin, Principal Accounting Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 1,709 shares at $2.82 ($5K) on 2008-07-31, disclosed to the SEC on 2008-08-04.
Open-market purchase of $5k BCRX by Principal Accounting Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |